Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.

NCT01809067 · View on ClinicalTrials.gov ↗

Study Summary

Research Question: What effect if any does the use of lavender aromatherapy have on a patient's stress and anxiety during the MRI procedure in the Cardiovascular Services Department? Hypothesis: 1. The use of lavender aromatherapy will reduce anxiety by 20% during MRI procedures. 2. MRI cancellations related to stress and anxiety will decrease by 10%. Sample size of 30 patients is needed for the control group and the lavender aromatherapy group, for a total of 60 patients. Rationale: Patients undergoing MRI procedures may experience stress and anxiety related to the small and confining space required during the scan. Anyone with a history of claustrophobia, panic attacks, or fear of enclosed spaces is more likely to experience symptoms of panic, fear, or anxiety during the MRI procedure (Harris, Cumming, \& Menzies, 2004, p. 1). This stress and anxiety may cause the patient to abort the scan, the patient may refuse future scans, or the patient's nervous tremors or involuntary quivering may adversely affect the images obtained. Lavender aromatherapy has been shown to reduce stress and anxiety for patients in other settings; however, its use during MRI procedures has not been studied. This project investigates the use of lavender aromatherapy as a non-pharmacological way to help patients relax during their MRI procedure. Lavender aromatherapy has been studied and shown to reduce stress and anxiety for patients in other situations, but it has not been studied during MRI procedures. Lavender is known to be uplifting, as well as soothing and helpful for reducing stress, anxiety, depression, and insomnia (Herz, 2007, p. 264). If aromatherapy proves useful as an agent to reduce stress and anxiety, patient satisfaction with their MRI procedure will increase and the need for sedating medication could decrease.

Conditions Studied

Interventions

  • OTHER Lavender aromatherapy inhalers

Study Locations (1)

Minnesota

  • Abbott Northwestern Hospital — Minneapolis

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-03
Est. Completion 2013-06
Phase NA

Sponsor

Allina Health System

8 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01809067

The ClinicalTrials.gov registry entry for NCT01809067 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allina Health System, which has 8 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention — of which Lavender aromatherapy inhalers is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT01809067 reports 1 study location spanning 1 distinct geographic area — top geographies include Minnesota. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT01809067 about?

NCT01809067 is a clinical study titled "The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.". Research Question: What effect if any does the use of lavender aromatherapy have on a patient's stress and anxiety during the MRI procedure in the Cardiovascular Services Department? Hypothesis: 1. The use of lavender aromatherapy will reduce anxiety by 20% during MRI procedures. 2. MRI cancellat...

What is the current status of trial NCT01809067?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-03. Estimated completion is 2013-06.

What conditions does trial NCT01809067 study?

This clinical trial studies the following conditions: Anxiety. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT01809067?

The interventions under investigation include: Lavender aromatherapy inhalers (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT01809067?

This trial is sponsored by Allina Health System, which has 8 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT01809067 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial